MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Stryker Corporation Total Assets 2011-2026 | SYK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Stryker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43 B | 39.9 B | 36.9 B | 34.6 B | 34.3 B | 30.2 B | 27.2 B | 22.2 B | 20.4 B | 16.2 B | 17.7 B | 15.7 B | 13.2 B | 12.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43 B | 12.4 B | 26 B |
Quarterly Total Assets Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 B | 46.3 B | 46 B | 43.8 B | 39.1 B | 39.4 B | 38 B | 37.4 B | 36.8 B | 36.9 B | 36 B | - | 36.1 B | 34.6 B | 34.1 B | 33.7 B | 33.5 B | 34.3 B | 34.3 B | 34.3 B | 34.3 B | 30.2 B | 30.2 B | 30.2 B | 30.2 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 22.2 B | 22.2 B | 22.2 B | 22.2 B | 20.4 B | 20.4 B | 20.4 B | 20.4 B | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 17.3 B | 17.7 B | 17.7 B | 17.7 B | 15.4 B | 15.7 B | 15.7 B | 15.7 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 12.1 B | 12.4 B | 12.4 B | 12.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.1 B | 12.1 B | 26 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
1.49 B | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 9.57 | 0.1 % | $ 687 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
776 M | $ 22.65 | -0.15 % | $ 3.24 B | USA |
 |
AxoGen
AXGN
|
204 M | $ 33.63 | 0.78 % | $ 1.49 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.5 | 1.16 % | $ 121 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 3.66 | -3.56 % | $ 136 M |  France |
 |
Electromed
ELMD
|
53.8 M | $ 28.9 | -0.41 % | $ 244 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 323.76 | 1.47 % | $ 9.13 B | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
39.4 B | $ 97.6 | -0.79 % | $ 144 B | USA |
 |
CONMED Corporation
CNMD
|
2.31 B | $ 43.07 | -2.56 % | $ 1.33 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 54.12 | 3.12 % | $ 8.06 K | USA |
 |
Abbott Laboratories
ABT
|
81.4 B | $ 125.84 | -0.27 % | $ 219 B | USA |
 |
InMode Ltd.
INMD
|
786 M | $ 14.47 | 1.47 % | $ 1.15 B | Israel |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.16 | -2.94 % | $ 18.7 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
|
LENSAR
LNSR
|
66.3 M | $ 11.6 | -0.6 % | $ 134 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
893 M | $ 15.77 | -2.65 % | $ 601 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 172.23 | 0.97 % | $ 12.9 B | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 0.89 | -0.47 % | $ 91.5 M | USA |
 |
IRadimed Corporation
IRMD
|
98.3 M | $ 98.81 | -1.19 % | $ 1.25 B | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 15.06 | -1.63 % | $ 407 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.56 | 0.02 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
15.4 M | $ 3.78 | -1.32 % | $ 14.1 M | USA |
 |
Sensus Healthcare
SRTS
|
62.2 M | $ 4.82 | 8.8 % | $ 78.6 M | USA |
 |
Globus Medical
GMED
|
5.25 B | $ 94.0 | -0.66 % | $ 12.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 13.69 | -1.23 % | $ 1.05 B | USA |